XML 91 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue from Contracts with Customers
12 Months Ended
Dec. 28, 2019
Revenue from Contracts with Customers [Abstract]  
Revenue from Contract with Customer

Note 17 – Revenue from Contracts with Customers

 

Revenue (Net sales) is recognized in accordance with the policies discussed in Note 1 – Significant Accounting Policies.

 

Disaggregation of Net sales

 

The following table disaggregates our Net sales by reportable segment and geographic area:

 

 

Year Ended

 

 

December 28, 2019

 

 

North America

 

International

 

Global

 

Revenues:

 

 

 

 

 

 

 

 

 

 

Health care distribution

 

 

 

 

 

 

 

 

 

 

 

Dental

$

3,911,746

 

 

2,504,119

 

 

6,415,865

 

 

 

Medical

 

2,894,137

 

 

79,449

 

 

2,973,586

 

 

 

 

 

Total health care distribution

 

6,805,883

 

 

2,583,568

 

 

9,389,451

 

 

Technology and value-added services

 

445,317

 

 

69,768

 

 

515,085

 

 

Total excluding Corporate TSA revenues (1)

 

7,251,200

 

 

2,653,336

 

 

9,904,536

 

 

Corporate TSA revenues (1)

 

4,098

 

 

77,169

 

 

81,267

 

 

 

Total revenues

$

7,255,298

 

$

2,730,505

 

$

9,985,803

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

December 29, 2018

 

 

North America

 

International

 

Global

 

Revenues:

 

 

 

 

 

 

 

 

 

 

Health care distribution

 

 

 

 

 

 

 

 

 

 

 

Dental

$

3,866,171

 

 

2,481,827

 

 

6,347,998

 

 

 

Medical

 

2,581,696

 

 

79,470

 

 

2,661,166

 

 

 

 

 

Total health care distribution

 

6,447,867

 

 

2,561,297

 

 

9,009,164

 

 

Technology and value-added services

 

344,168

 

 

64,271

 

 

408,439

 

 

Total excluding Corporate TSA revenues (1)

 

6,792,035

 

 

2,625,568

 

 

9,417,603

 

 

Corporate TSA revenues (1)

 

-

 

 

-

 

 

-

 

 

 

Total revenues

$

6,792,035

 

$

2,625,568

 

$

9,417,603

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

Corporate TSA revenues represents sales of certain animal health products to Covetrus under the transition services agreement

 

 

entered into in connection with the Animal Health Spin-off, which we expect to continue through August 2020.